86
Participants
Start Date
July 31, 2006
Study Completion Date
May 31, 2007
Celecoxib
Celecoxib 400 mg BID with creatine 10 g BID if randomized to the Celecoxib + Creatine study arm.
Creatine
10 g BID for either study arm
Minocycline
Minocycline 100 mg BID with creatine 10 g BID if randomized to the Minocycline + Creatine study arm
Beth Israel, New York
Columbia University, New York
University of Pennsylvania, Philadelphia
Duke University, Durham
Medical College of Georgia, Augusta
Mayo Clinic Florida, Jacksonville
Mayo Clinic Rochester, Rochester
University of Illinois, Chicago
Washington University, St Louis
University of Kansas, Kansas City
UT Southwestern Medical Center, Dallas
Phoenix Neurological Associates, Phoenix
University of New Mexico, Albuquerque
UCLA, Los Angeles
University of California Irvine, Orange
California Pacific Medical Center, San Francisco
Oregon Health and Science University, Portland
UMDNJ, New Brunswick
University of Vermont, Burlington
Collaborators (1)
ALS Association
OTHER
Pfizer
INDUSTRY
Columbia University
OTHER